| TTM
|
4/30/2026
|
4/30/2025
|
4/30/2024
|
4/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,591,045 | 1,335,116 | 436,775 | 192,970 | 184,194 |
| Cost of Revenue
|
-523,984 | -426,767 | -153,866 | -73,539 | -78,000 |
|
Gross Profit
|
1,067,061 | 908,349 | 282,909 | 119,431 | 106,194 |
|
Selling, General and Administrative Expenses
|
-220,641 | -183,963 | -98,918 | -60,193 | -48,248 |
|
Research and Development Expenses
|
-341,457 | -279,381 | -146,867 | -96,296 | -76,774 |
|
Operating Income/Expenses
|
-562,098 | -463,344 | -245,785 | -156,489 | -125,022 |
|
Total Operating Profit/Loss
|
504,963 | 445,005 | 37,124 | -37,058 | -18,828 |
| Irregular Income/Expenses
|
-873 | -- | -873 | -765 | -2,407 |
|
Other Income/Expense, Non-Operating
|
34,624 | 30,430 | 17,746 | 14,313 | 3,321 |
|
Non-Operating Income/Expenses, Total
|
34,624 | 30,430 | 17,746 | 14,313 | 914 |
|
Pretax Income
|
539,587 | 475,435 | 54,870 | -22,745 | -17,914 |
|
Provision for Income Tax
|
-1,282 | -3,156 | -2,687 | -5,624 | 1,367 |
|
Net Income from Continuing Operations
|
538,305 | 472,279 | 52,183 | -28,369 | -16,547 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
538,305 | 472,279 | 52,183 | -28,369 | -16,547 |
|
Net Income after Non-Controlling/Minority Interests
|
538,305 | 472,279 | 52,183 | -28,369 | -16,547 |
|
Net Income Available to Common Stockholders
|
538,305 | 472,279 | 52,183 | -28,369 | -16,547 |
|
Diluted Net Income Available to Common Stockholders
|
538,305 | 472,279 | 52,183 | -28,369 | -16,547 |
| Basic EPS
|
2.96 | 2.65 | 0.31 | -0.18 | -0.11 |
| Diluted EPS
|
2.82 | 2.51 | 0.29 | -0.18 | -0.11 |
|
Basic Weighted Average Shares Outstanding
|
182,058 | 178,538 | 167,505 | 155,091 | 146,556 |
|
Diluted Weighted Average Shares Outstanding
|
190,682.25 | 188,232 | 181,158 | 155,091 | 146,556 |
|
Reported Normalized Diluted EPS
|
4.10 | 3.46 | 0.70 | 0.09 | 0.05 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
539,587 | 475,435 | 54,870 | -22,745 | -17,914 |
|
EBITDA
|
589,370 | 510,472 | 76,808 | -8,974 | -8,400 |
|
Normalized EBITDA
|
841,566 | 709,726 | 176,174 | 39,092 | 24,436 |
|
Normalized Income
|
799,523 | 661,543 | 129,926 | 14,570 | 8,687 |
|
Total Unusual Items
|
252,196 | 199,254 | 99,366 | 48,066 | 32,836 |
|
Total Unusual Items Excluding Goodwill
|
252,196 | 199,254 | 99,366 | 48,066 | 32,836 |
|
Tax Effect of Unusual Items
|
599.22 | 1,992.54 | 4,968.30 | 0 | 2,626.88 |
4/30/2023 - 1/27/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade